StreetAlpha.app
Home › Stocks › BRVE

Braveheart Bio, Inc. (BRVE)

$18.78
▼ −3.64%
LAST CLOSE · NOV 17

Braveheart Bio, Inc. (BRVE) tracked by StreetAlpha. It last closed at $18.78 on Nov 17, down 3.64% on the day. BRVE reports earnings on Tue, Feb 9, 2027. The average 12-month price target from 4 analysts is $45.25 (+140.9% from the last close), with a high of $48.00 and a low of $40.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell).

AI Auto Pilots
Is BRVE in one of our four AI portfolios? Sign in free to see
Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
-$0.44
 
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
4firms
4 Buy0 Hold0 Sell
Each firm's latest rating on BRVE in the past 90 days
Average 12-month target
$45.25
▲ 140.9% upside

Based on 4 analysts who set a price target on BRVE in the past 90 days. The average target is $45.25, with a high of $48.00 and a low of $40.00, compared with the last close of $18.78.

Low $40.00Avg $45.25High $48.00
Blue marker: last close $18.78
Highest target$48.00
Average target$45.25
Lowest target$40.00
Latest rating changes
Goldman SachsInitiated
Aug 31Buy$48
JefferiesInitiated
Aug 31Buy$48
Cantor FitzgeraldInitiated
Aug 31Buy$40
StifelInitiated
Aug 31Buy$45
DateFirmActionRatingPrice target
Aug 31Goldman SachsInitiatedBuy$48
Aug 31JefferiesInitiatedBuy$48
Aug 31Cantor FitzgeraldInitiatedBuy$40
Aug 31StifelInitiatedBuy$45
Loading…

Technical Analysis

BRVE · as of the Nov 17 close · updated after every close
Falling

The stock is 9% below its 20 day and 16% below its 50 day average. Momentum is weak (RSI 41). The nearest support is the Pivot at $18.68, and the nearest resistance the Pivot R1 at $19.56.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 8.7%/day
Key levels
$32.0052 week high+70.4%
$21.7250 day average+15.7%
$20.78Swing high (Oct 12)+10.6%
$20.4520 day average+8.9%
$19.56Pivot R1+4.2%
$18.78Last close
$18.68Pivot−0.5%
$18.00Swing low (Oct 16)−4.2%
$17.89Pivot S1−4.7%
$16.7052 week low−11.1%
Indicators
RSI (14)41.25Middle of its rangeNeutral
MACD-0.59Below its signal lineBearish
Stochastic47.1Middle of its rangeNeutral
ADX (14)21.4Weak trend
Williams %R-62.2Oversold below −80, overbought above −20Neutral
CCI (20)-113.9Oversold below −100, overbought above 100Oversold
Rate of change−12.2%Change over 10 sessionsBearish
ATR (14)$1.63Typical daily range, 8.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for BRVE

What happened before

See how BRVE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in BRVE in the last 90 days.

Loading…

See today’s whale options flow across the market →

BRVE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲64 buying vs 0 selling
  • ●Shares held by funds +0.0%
  • ●Funds holding +64
  • ▲Superinvestors: 2 added, 0 cut
  • ●Put/call not meaningful
Q3 2026This quarterLast quarterChange
Funds holding64––
In funds' top 105––
Held by funds–––
New / increased64 / 0––
Reduced / sold out0 / 0––
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BRVE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BRVE is in one of them and how their past BRVE trades turned out.

BRVE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BRVE in an article yet. Here's the latest on the wider market.